In-vitro Diagnostics Market Share

The North America in-vitro diagnostics market is projected to hold the largest market share by the end of 2037. The market in North America is driven by the increasing requirement of genetic testing for personalized health care, diabetes, and cancer. According to the International Diabetes Federation (IDF), it was estimated that around 32.2 million people in the U.S., were suffering from diabetes in 2021. On the other hand, the market in the Asia Pacific region is also expected to be the fastest-growing regional market during the forecast period, with driving factors such s, the presence of stabilizing economies, the rapid growth of the middle-class population, and rapid urbanization.